How common is insomnia in perimenopause?
Sleep disruption is one of the most common — and most undertreated — experiences of the menopause transition. Roughly 40–60% of women report meaningful sleep problems during this period.11 That is not a vague feeling. A systematic review of 24 studies found that women in perimenopause had 60% higher odds of disrupted sleep compared to premenopausal women, and the odds climbed even higher after menopause and after surgical menopause.11
The pattern matters too. Sleep maintenance — the ability to stay asleep once you are down — is more affected than sleep onset, which is why so many women describe falling asleep fine and then finding themselves awake in the small hours. Long-term SWAN data adds another layer: Black and Hispanic/Latinx women reported higher rates of interrupted sleep than White women, which points to real differences in how the transition is experienced across communities.22
If your sleep has quietly come apart in your forties and nobody flagged it as a perimenopause symptom, that is the gap in care doing what it does. The problem is not you.
What is perimenopause doing to your sleep?
The short answer: several things at once, and they compound each other.
Estradiol and progesterone do real work in your sleep architecture — they influence how deeply you sleep, how stable your body temperature stays overnight, and how easily external signals can tip you out of sleep. As these hormones become more erratic in perimenopause, the structure of your sleep becomes more erratic too. Research using a GnRH-agonist model (a method that recreates estrogen withdrawal experimentally) showed that estradiol loss alone increases arousals and stage transitions during the night — meaning more surface-skimming, more moments where a small thing can wake you.33
Add hot flashes into that already-lighter sleep, and the disruption multiplies. Vasomotor symptoms — the medical term for hot flashes and night sweats — do not need to be dramatic or even consciously felt to break your sleep. Night-time hot flashes measured with skin sensors occur more frequently than women recall in the morning. The signal is real even when the heat is not obvious.
Then a third force develops over time: behavioral. After weeks or months of bad nights, your nervous system starts associating the bed itself with wakefulness and frustration. This is called conditioned arousal, and it is why insomnia can persist even after the hormonal picture improves — and why a purely hormonal fix often is not enough on its own.
What is the most effective treatment for perimenopausal insomnia?
The most effective first-line treatment is not a pill. It is a structured behavioral program called CBT-I — cognitive behavioral therapy for insomnia.
CBT-I works by identifying and gradually dismantling the thought patterns and sleep habits that keep insomnia running long after the original trigger has passed. The results in menopausal women are clinically significant. In one rigorously designed trial, women with chronic insomnia who did CBT-I saw their insomnia severity score drop by 7.70 points — compared to just 1.12 points for those who received sleep hygiene education alone.55 Remission rates (meaning insomnia fully resolved) ranged from 54 to 84% in the CBT-I group.55 The effects hold. In the MsFLASH trial, telephone-delivered CBT-I reduced insomnia severity in perimenopausal and postmenopausal women compared to a menopause education control — and the approach worked over the phone, which matters for women who do not have easy access to an in-person sleep specialist.44
What about hormone therapy, sleep aids, and melatonin?
They each occupy a different place in the picture.
Hormone therapy (HT): When hot flashes are the specific engine driving your broken sleep, treating the hot flashes treats the sleep. Hormone therapy is the most effective option for vasomotor symptoms, and for women where VMS is the main cause of disruption, it can meaningfully improve sleep quality.66 It is not a universal sleep solution — but for the right candidate, it addresses the root cause rather than the symptom.
Prescription sleep aids: Low-dose hypnotics such as eszopiclone and zolpidem can help in the short term. They are not first-line because they carry real concerns: tolerance, dependence, and increased falls risk — especially relevant as women move through midlife. Trazodone is commonly prescribed off-label and has modest supporting evidence. Any prescription sleep aid is best used as a short bridge, not an ongoing solution.
Melatonin: It is widely sold and widely tried. The evidence for melatonin as a treatment for perimenopausal insomnia specifically is weak.33 It is not a reliable fix for this type of sleep problem.
Alcohol: Worth naming plainly. Alcohol is one of the most potent suppressors of deep, restorative sleep — the stages you are already getting less of. Even one or two drinks in the evening measurably worsen sleep architecture. It may help you feel drowsy at bedtime while guaranteeing you lighter, more fragmented sleep in the second half of the night.
A few practical anchors that work alongside any treatment:
- Consistent wake time — even after a rough night. It is the strongest single signal you can give your body's sleep clock.
- Cool sleeping environment — 60–67°F (15–19°C) reduces the temperature fluctuation that tips hot flashes and arousals.
- Wind-down buffer — the hour before bed matters more than most sleep products sold for this purpose.
Does it ever get better on its own?
For some women, yes — particularly when the hot-flash-driven disruption eases. But for many, the behavioral layer that develops over months of bad nights (the conditioned arousal, the hypervigilance about sleep) persists independently. That is the piece CBT-I addresses directly, and it is why waiting it out often does not produce the resolution women hope for. The good news is that the most effective treatment — CBT-I — does not require a prescription and has no dependence risk. CBT-I is also available in digital and online formats, which can improve access for women who cannot reach an in-person program. The telephone-based format studied in MsFLASH works.44 The barrier is usually awareness, not access.